Genmab: Darzalex Growth Fuels Rally, Upside Is Tight

January 23, 2026 09:50:47 am

Source: SeekingAlpha

2026-01-23 09:50:47 ET

Genmab ( GMAB ) is becoming a prominent player in the cancer and multiple sclerosis therapeutics markets....

For further details see:

Novartis AG

-3.4% G/L:

$145.35 Last:

1,290,757 Volume:

$146.92 Open:

April 17, 2026 02:57:00 pm

April 01, 2026 08:27:57 am

March 03, 2026 09:50:00 am

February 24, 2026 04:52:00 pm

Market Cap $303,205,301,793

Float 1,889,070,162

Insiders Ownership N/A

Institutions 868

Short Percent N/A

Industry Pharmaceuticals

Sector Healthcare

Country CH

City Basel